Frequently Asked Questions
1. What types of content does Medvix publish?
We publish Case Reports, Research Papers, Review Articles, and Editorials in various fields, including medicine, healthcare, and social sciences.
2. Is Medvix an Open Access journal?
Yes, Medvix is an open-access journal, meaning all published content is available free to readers worldwide without any subscription.
3. How often does Medvix publish articles?
Medvix publishes 1 Issue every month. This ensures timely dissemination of the latest research and updates.
4. What is the Open Peer Review process?
All submissions undergo a rigorous peer review, where experts in the relevant field evaluate the work for quality, accuracy, and significance. The author knows who is reviewing their work, and the reviewer knows whose work they are evaluating.
5. What is the advantage of Open Peer Review?
The review process is transparent and of high integrity, as both the author and the reviewer know each other's identities.
6. Is there a fee for publishing on Medvix?
Yes, an Article Processing Charge (APC) is charged. It covers the cost of DOI registration, plagiarism checking, proofreading, indexing, editing, formatting, production, maintaining the journal's infrastructure, and open-access distribution.
7. How long does it take to review and publish a manuscript?
The review process typically takes 2 to 3 weeks, and accepted manuscripts are published online within 2 weeks after final approval.
8. Does Medvix provide support to authors in the submission process?
Yes, our editorial team is available to guide authors through the submission process and provide support in manuscript preparation.
9. What are the benefits of publishing with Medvix?
Publishing with Medvix offers global visibility, fast publication timelines, a rigorous peer review process, and an opportunity to contribute to a diverse, international research community.
10. What licensing does Medvix use for its publications?
All articles are published under the Creative Commons Attribution International (CC BY 4.0) license, allowing free distribution, reuse, and adaptation with proper attribution.